The Department of Science and Technology (DOST) said Friday, Nov. 26, that initial results of the clinical study on tawa-tawa (Euphorbia hirta) as adjunctive treatment for coronavirus disease showed that tawa-tawa capsules are safe for patients who are experiencing mild COVID-19 symptoms.